Clinical Trials

Neoplasms

NCT05237349 2024-01-05

Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma

38 enrolled

Neoplasm Metastasis

NCT05876806 2023-11-30

Dabrafenib Plus Trametinib in Patients With Advanced Solid Tumor Having BRAF V600E Mutation or Clinically Actionable BRAF Gene Alterations

Neoplasms

NCT04717674 2023-10-03

[18F]FPIA

21 enrolled

Neoplasms

NCT06047860 2023-09-21

A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer

Neoplasms

NCT05904457 2023-06-15

BRISK

32 enrolled

Neoplasm Metastasis, Neoplasms

NCT05790447 2023-03-30

Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors

60 enrolled

Neoplasms

NCT04985721 2023-03-15

IMPARP-HRD

60 enrolled

Neoplasms

NCT05686213 2023-02-08

ExeNTrO

39 enrolled

Neoplasms

NCT04225767 2022-12-13

CaEP-R

19 enrolled

Neoplasms

NCT03697707 2022-10-10

ADVANCE-II

Neoplasm, Residual

NCT05530200 2022-09-07

PRaG Regimens Rechallenge for Patients With Resistance to PD1/PD-L1 Inhibitors in Refractory Advanced Solid Tumors.

56 enrolled

Neoplasm Metastasis

NCT02461849 2022-06-15

Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib Therapy

14 enrolled

Neoplasms

NCT02366884 2022-04-06

Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011)

250 enrolled

Neoplasms

NCT03239015 2022-03-04

Efficacy and Safety of Precision Therapy in Refractory Tumor

300 enrolled

Neoplasms

NCT05241132 2022-02-15

Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary

27 enrolled

Neoplasms

NCT05115500 2021-11-10

ADC Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of HER-2 Positive Advanced Solid Tumors(PRaG3.0)

55 enrolled

Carcinoma

NCT04699071 2021-10-21

Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)

10 enrolled

Adenocarcinoma

NCT04547829 2021-09-02

Safety and Efficacy of PEG-rhG-CSF in Preventing Neutropenia in Children With Tumor After Chemotherapy

108 enrolled

Neoplasms

NCT03564548 2021-07-28

REBORN

Neoplasms

NCT04780854 2021-07-28

Drug Repurposing for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN)

68 enrolled

Neoplasms

NCT02795650 2021-02-26

AVATAR

146 enrolled

Adenocarcinoma, Neoplasm Metastasis

NCT04761744 2021-02-21

A Phase II Study of Nivolumab in Patients With Genetic Alterations in DNA Damage Repair and Response Who Progressed After Standard Treatment for Metastatic Solid Cancers

48 enrolled

Neoplasm Metastasis

NCT02029937 2021-01-14

High Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia

1,300 enrolled

Neoplasms

NCT04710472 2021-01-14

MentorA1

50 enrolled

Neoplasms

NCT04695223 2021-01-06

Arsenic Trioxide for Structural p53 Mutations

Neoplasms

NCT04698213 2021-01-06

TIDE-A

75 enrolled

Carcinoma, Neoplasm Metastasis

NCT04647838 2020-12-02

Tepotinib in Solid Tumors Harboring MET Alterations

100 enrolled

Neoplasms

NCT03113266 2020-09-30

Safety and Efficacy of Toripalimab for Patients With Locally Advanced or Metastatic Bladder Urothelial Carcinoma

370 enrolled

Neoplasm Metastasis

NCT04533321 2020-08-31

A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell Carcinoma

Carcinoma, Squamous Cell

NCT04131621 2020-04-15

CheCUP

194 enrolled

Neoplasms, Unknown Primary

NCT02670109 2020-01-14

Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients

Neoplasm, Residual

NCT01682772 2019-08-15

TOPARP

148 enrolled

Adenocarcinoma

NCT03864575 2019-07-12

NICE-COMBO

68 enrolled

Neoplasm Metastasis

NCT03299452 2019-02-15

Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor

50 enrolled

Neoplasm Metastasis

NCT03693326 2018-10-03

PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnormalities

70 enrolled

Neoplasms

NCT03693339 2018-10-03

Capmatinib in Patients With Non-small Cell Lung Cancer Harboring cMET exon14 Skipping Mutation

27 enrolled

Neoplasms

NCT03588533 2018-07-17

HERZUMA-GC

50 enrolled

Neoplasm Metastasis

NCT03543306 2018-06-01

Dabrafenib and Trametinib in Patients With Non-small Cell Lung Cancer Harboring V600E BRAF Mutation

27 enrolled

Neoplasms

NCT03486509 2018-04-03

Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell Carcinoma

2 enrolled

Carcinoma, Squamous Cell

NCT03402464 2018-01-18

Icotinib Combined With Dihydroaremisinin (DHA) Therapy in Patients With Advanced NSCLC

Adenocarcinoma

NCT03341286 2017-11-14

TK3bFIIABC

140 enrolled

Neoplasms

NCT03158324 2017-06-15

Phase IIa Dose-Expansion and Biomarker Study of OPB-111077

52 enrolled

Neoplasms

NCT02674646 2016-02-04

ROSETTA

74 enrolled

Neoplasms

NCT02590055 2015-10-28

Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary

29 enrolled

Neoplasms, Unknown Primary

NCT02530411 2015-08-21

FURVA

160 enrolled

Neoplasms

NCT01232374 2015-08-20

Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma

144 enrolled

Carcinoma, Squamous Cell

NCT00943137 2015-06-19

The Optimization of 5-Fluorouracil Dose by Pharmacokinetic Monitoring in Asian Patients With Advanced Stage Cancer

55 enrolled

Neoplasms

NCT02400866 2015-03-27

A Randomized Study of Olanzapine for the Prevention of CINV in Patients Receiving Moderately Emetogenic Chemotherapy

58 enrolled

Neoplasms

NCT02340845 2015-01-19

Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans

100 enrolled